Trial intelligence / Profile preview

Low-dose oral minoxidil versus topical minoxidil for androgenetic alopecia

IRCT20210823052264N7Phase 3Completed

Sponsor
Combined Military Hospital Quetta
Start
Jun 2024
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of minoxidil in androgenetic alopecia (AGA) (2 arms), sponsored by Combined Military Hospital Quetta. Started Jun 2024; status: completed.

02

Drugs

minoxidil
03

Conditions

androgenetic alopecia (AGA)

Beyond the preview

Go deeper on IRCT20210823052264N7.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20210823052264N7.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call